Zeo ScientifiX (ZEOX) Asset Utilization Ratio (2013 - 2026)
Zeo ScientifiX (ZEOX) posted quarterly Asset Utilization Ratio of 2.16 for Q2 2026, down 29.38% year-over-year from 3.06 in Q2 2025, and down 20.17% quarter-over-quarter from 2.71 in Q1 2026.
Zeo ScientifiX (ZEOX) Asset Utilization Ratio (2013 - 2026) Analysis & Trends
Zeo ScientifiX's Asset Utilization Ratio history runs 13 years deep, the most recent figure standing at 2.16 for Q2 2026.
- In Q2 2026, Asset Utilization Ratio fell 29.38% year-over-year to 2.16; the TTM figure through Apr 2026 stood at 2.16 (down 29.38% YoY), while the FY2025 annual figure was 3.28, up 57.08% from the prior year.
- Asset Utilization Ratio for Q2 2026 stood at 2.16, down from 2.71 in the prior quarter.
- The five-year high for Asset Utilization Ratio was 3.27 in Q4 2025, with the low at 1.13 in Q1 2023.
- The 5-year median for Asset Utilization Ratio is 2.35 (2024), against an average of 2.33.
- The sharpest annual moves came in 2023 and 2024: Asset Utilization Ratio sank 60.98% in 2023, then surged 70.38% in 2024.
- Zeo ScientifiX's Asset Utilization Ratio stood at 1.48 in 2022, then rose by 17.42% to 1.74 in 2023, then jumped by 37.39% to 2.39 in 2024, then soared by 36.78% to 3.27 in 2025, then plunged by 33.83% to 2.16 in 2026.
- Business Quant data shows ZEOX's Asset Utilization Ratio at 2.16 in Q2 2026, 2.71 in Q1 2026, and 3.27 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.71 Bn | 130.86 Bn | 2.84 Bn | 0.47 |
| 2 | Regeneron Pharmaceuticals | 85.60 Bn | 77.60 Bn | 3.93 Bn | 0.38 |
| 3 | Argenx Se | 64.82 Bn | 59.63 Bn | 1.37 Bn | - |
| 4 | Moderna | 57.92 Bn | 52.79 Bn | 52.00 Mn | 0.20 |
| 5 | BeOne Medicines | 41.88 Bn | 36.78 Bn | 1.53 Bn | 0.69 |
| 6 | Alnylam Pharmaceuticals | 31.46 Bn | 28.15 Bn | 992.69 Mn | 0.90 |
| 7 | BioNTech SE | 27.96 Bn | 9.57 Bn | 668.28 Mn | 0.13 |
| 8 | Insmed | 27.35 Bn | 26.19 Bn | 358.27 Mn | 0.54 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 0.13 |
| 10 | Zeo ScientifiX | 10.51 Mn | 8.67 Mn | 2.06 Mn | 2.16 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 2.16 |
| Jan 31, 2026 | 2.71 |
| Oct 31, 2025 | 3.27 |
| Jul 31, 2025 | 3.10 |
| Apr 30, 2025 | 3.06 |
| Jan 31, 2025 | 2.85 |
| Oct 31, 2024 | 2.39 |
| Jul 31, 2024 | 2.31 |
| Apr 30, 2024 | 2.26 |
| Jan 31, 2024 | 1.78 |
| Oct 31, 2023 | 1.74 |
| Jul 31, 2023 | 1.58 |
| Apr 30, 2023 | 1.33 |
| Jan 31, 2023 | 1.13 |
| Oct 31, 2022 | 1.48 |
| Jul 31, 2022 | 2.81 |
| Apr 30, 2022 | 2.97 |
| Jan 31, 2022 | 2.91 |
| Oct 31, 2021 | 3.07 |
| Jul 31, 2021 | 3.25 |